Economic benefits of safety-engineered sharp devices in Belgium - A budget impact model

BMC Health Services Research

Volumn 13, Issue 1, 2013, Pages

  Hanmore, Emma ^a   Maclaine, Grant ^b   Garin, Fiona ^c   Alonso, Alexander ^d   Leroy, Nicolas ^d   Ruff, Lewis ^a  

^a Medaxial Limited   (United Kingdom)

^b Becton Dickinson UK Limited   (United Kingdom)

^c Dickinson SA   (Spain)

^d Becton Dickinson Benelux NV ^*  (Belgium)

Author keywords

Budget; Device; Economic; Model; Needlestick; Safety engineered

Indexed keywords

ACCIDENTS, OCCUPATIONAL; BELGIUM; BUDGET; COST CONTROL; ECONOMICS; HEALTH CARE COST; HOSPITAL PERSONNEL; HUMAN; NEEDLESTICK INJURIES; PROTECTIVE EQUIPMENT; STATISTICS AND NUMERICAL DATA; ARTICLE; NEEDLESTICK INJURY; OCCUPATIONAL ACCIDENT; STATISTICS;

ACCIDENTS, OCCUPATIONAL; BELGIUM; BUDGETS; COST SAVINGS; HEALTH CARE COSTS; HUMANS; NEEDLESTICK INJURIES; PERSONNEL, HOSPITAL; PROTECTIVE DEVICES;

EID: 84888082764     PISSN: None     EISSN: 14726963     Source Type: Journal    
DOI: 10.1186/1472-6963-13-489     Document Type: Article

References (53)

1. Royal College of Nursing, RCN guidance to support implementation of the EU Directive 2010/32/EU on the prevention of sharps injuries in the health care sector London, UK: Royal College of Nursing 2011
2. International Healthcare Worker Safety Center, University of Virginia, 2009 EPINet Report for Needlestick and Sharp Object Injuries Sharps Injury Charlottesville VA, USA: International Healthcare Worker Safety Centre 2011
3. European Biosafety Network, Toolkit for the implementation of European Directive on prevention from sharps injuries (Council Directive 2010/32/EU) in member states 2011 http://www.europeanbiosafetynetwork.eu/EBN%20Toolkit%202011. pdf
4. Sharps injuries in UK health care: a review of injury rates, viral transmission and potential efficacy of safety devices. Elder A, Paterson C, Occup Med 2006 56 566 574 10.1093/occmed/kql122 (Pubitemid 44963777)
5. Canadian Centre for Occupational Health and Safety: OSH answers: needlestick injuries http://www.ccohs.ca/oshanswers/diseases/needlestick- injuries.html
6. Determination of risk of infection with blood-borne pathogens following a needlestick injury in hospital workers. Wicker S, Cinatl J, Berger A, Doerr HW, Gottschalk R, Rabenau HF, Ann Occup Hygiene 2008 52 615 622 10.1093/annhyg/men044
7. European Biosafety Network, Prevention of sharps injuries in the hospital and healthcare sector: implementation guidance for the EU Framework Agreement, Council Directive and Associated National Legislation 2010 http://www. europeanbiosafetynetwork.eu/EU%20Sharps%20Injuries%20Implementation%20Guidance. pdf
8. Scotland NHS, Safer sharps devices: an evaluation of utility in NHS Scotland Edinburgh, UK: Scottish Executive Health Department 2005
9. Needlestick injuries: incidence and cost in the United States, United Kingdom, Germany, France, Italy, and Spain. Saia M, Hofmann F, Sharman J, Abiteboul D, Campins M, Burkowitz J, Choe YH, Kavanagh S, Biomed Int 2010 1 41 49
10. Health care workers' experience with postexposure management of bloodborne pathogen exposures: a pilot study. Gershon RR, Flanagan PA, Karkashian C, Grimes M, Wilburn S, Frerotte J, Guidera J, Pugliese G, Am J Infect Control 2000 28 421 428 10.1067/mic.2000.109907 11114612 (Pubitemid 32006291)
11. Mental health of healthcare workers who experience needlestick and sharps injuries. Sohn JW, Kim BG, Kim SH, Han C, J Occup Health 2006 48 474 479 10.1539/joh.48.474 17179640 (Pubitemid 46057879)
12. Needlestick injury in acute care nurses caring for patients with diabetes mellitus: a retrospective study. Lee JM, Botteman MF, Nicklasson L, Cobden D, Pashos CL, Curr Med Res Opin 2005 21 741 747 10.1185/030079905X46205 15969873 (Pubitemid 40695296)
13. Needlestick injuries in the United States. Epidemiologic, economic, and quality of life issues. Lee JM, Botteman MF, Xanthakos N, Nicklasson L, AAOHN J 2005 53 117 134 15789967
14. COUNCIL DIRECTIVE 2010/32/EU of 10 May 2010 implementing the framework agreement on prevention from sharp injuries in the hospital and healthcare sector concluded by HOSPEEM and EPSU2010. Council of the European Union, Off J Eur Union 2010 53 L134 66 73
15. Role of safety-engineered devices in preventing needlestick injuries in 32 French hospitals. Lamontagne F, Abiteboul D, Lolom I, Pellissier G, Tarantola A, Descamps JM, Bouvet E, Infect Control Hosp Epidemiol 2007 28 18 23 10.1086/510814 17230383 (Pubitemid 46219220)
16. Principles of good practice for budget impact analysis: report of the ISPOR task force on good research practices-budget impact analysis. Mauskopf JA, Sullivan SD, Annemans L, Caro J, Mullins CD, Nuijten M, Orlewska E, Watkins J, Trueman P, Value Health 2007 10 336 347 10.1111/j.1524-4733.2007.00187.x 17888098 (Pubitemid 47481105)
17. Portail des services publics belges, Portail des services publics belges http://www.belgium.be/fr/sante/soins-de-sante/services-medicaux/hopitaux
18. Risk of needlestick injuries by injection pens. Pellissier G, Miguéres B, Tarantola A, Abiteboul D, Lolom I, Bouvet E, GERES Group, J Hosp Infect 2006 63 60 64 10.1016/j.jhin.2005.12.006 16540200
19. Needlestick injuries and infectious patients in a major academic medical centre from 2003 to 2010. Frijstein G, Hortensius J, Zaaijer HL, Neth J Med 2011 69 465 458 22058270
20. Transmission and postexposure management of bloodborne virus infections in the health care setting: where are we now? Moloughney BW, CMAJ 2001 165 445 451 11531058 (Pubitemid 32885428)
21. Risk and management of blood-borne infections in health care workers. Beltrami EM, McArthur MA, McGeer A, Armstrong-Evans M, Lyons D, Chamberland ME, Cardo DM, Clin Microbiol Rev 2000 13 385 407 10.1128/CMR.13.3.385-407.2000 10885983 (Pubitemid 30452613)
22. European survey of hepatitis B vaccination policies for healthcare workers. De Schryver A, Claesen B, Meheus A, van Sprundel M, François G, Eur J Public Health 2011 21 338 343 10.1093/eurpub/ckq122 20817688
23. Europe WHO, HIV/AIDS treatment and care Copenhagen: Clinical protocols for the WHO European Region 2007
24. Institut Scientifique de Santé Publique, National surveillance of occupational blood exposure. Cumulative report: needlesticks and sharp-object injuries 2003-9 Brussels, Belgium: Institut Scientifique de Santé Publique 2010
25. Institut National d'Assurance Maladie-Invalidité: Spécialités pharmaceutiques http://www.inami.fgov.be/inami-prd/ ssp/cns2/pages/SpecialityCns.asp
26. Institut National d'Assurance Maladie-Invalidité: Honoraires, prix et remboursements-Tarifs 2012 http://www.inami.fgov.be/insurer/fr/rate/index. htm
27. Kumar P, Clark M, Clinical Medicine St Louis MO, USA: Saunders (W.B.) Company Ltd 8 2012
28. Smith A, Craggs S, Newcastle-upon-Tyne Hospitals NHS Foundation Trust: Clinical Governance. Policy No: NoT MD10. Needlestick injuries and blood borne virus exposure: Code of practice Newcastle-upon-Tyne, UK: NHS North of Tyne 2009
29. Guidance on the investigation and management of occupational exposure to hepatitis C PHLS advisory committee on blood borne viruses. Ramsay ME, Comm Dis Public Health 1999 2 258 262
30. Prevalence of hepatitis C antibodies in a large sample of Belgian healthcare workers. Moens G, Vranckx R, De Greef L, Jacques P, Infect Control Hosp Epidemiol 2000 21 209 212 10.1086/501746 10738992
31. Safety producten, een (financieel) voordeel voor allen. Larmuseau D, MD News 2007 2 20 22
32. Ordré des Medecins: Suivi des accidents par piqûre http://www.ordomedic.be/fr/avis/conseil/suivi-des-accidents-par-piqure
33. Société Belge d'infectiologie et de microbiologie Clinique: Healthcare occupational exposure http://www.sbimc.org/PEP%202009%20v4.pdf
34. National Institute for Health and Clinical Excellence, Costing statement: Tenofovir disoproxil for the treatment of chronic hepatitis B London, UK: National Institute for Health and Clinical Excellence 2009
35. Roche Products Limited, Summary of Product Characteristics. Pegasys 135mcg and 180mcg solution for injection in Pre-filled Syringe Welwyn Garden City, UK: Roche Products Limited 2011
36. National Institute of Health and Clinical Excellence, Technology Appraisal Guidance 75. Interferon alfa (pegylated and non-pegylated) and ribavirin for the treatment of chronic hepatitis C London, UK: National Institute for Health and Clinical Excellence 2004
37. Rising population cost for treating people living with HIV in the UK, 1997-2013. Mandalia S, Mandalia R, Lo G, Chadborn T, Sharott P, Youle M, Anderson J, Baily G, Brettle R, Fisher M, Gompels M, Kinghorn G, Johnson M, McCarron B, Pozniak A, Tang A, Walsh J, White D, Williams I, Gazzard B, Beck EJ, NPMS-HHC Steering Group, PLoS One 2010 5 15677 10.1371/journal.pone.0015677 21209893
38. OANDA, Historical exchange rates http://www.oanda.com/currency/ historical-rates
39. Introducing safety syringes into a UK dental school- a controlled study. Zakrzewska JM, Greenwood I, Jackson J, Br Dent J 2001 190 88 92 11213339 (Pubitemid 33755311)
40. Nationaal Hepatitis Centrum, Het verminderen van prikaccidenten door inzet van veiligheidssystemen Amersfoort, Netherlands: Nationaal Hepatitis Centrum 2009
41. Statistics Belgium, Coût de la main-d'oeuvre portant sur l'année civile 2008-la répartition des dépenses en % du coût total de la main-d'oeuvre par NACE Rev. 2 http://statbel.fgov.be/fr/ modules/publications/statistiques/marche-du-travail-et-conditions-de-vie/ enquete-quadriennale-co-t-de-la-main-d-uvre-2008.jsp
42. Hospital fined after health worker infected with Hepatitis C http://www.hse.gov.uk/press/2010/coi-wm-17710.htm
43. Thompsons Solicitors: Unison calls for safer needles following needlestick injury http://www.thelegalline.co.uk/accidents-at-work-needlestick- injury-compensation-claims.aspx
44. The legal line, Hospital worker makes needlestick compensation claim http://www.thelegalline.co.uk/accidents-at-work-needlestick-injury-compensation- claims.aspx
45. Federaal Kenniscentrum voor de Gezondheidszorg, Guidelines for pharmacoeconomic evaluations in Belgium Brussels: KCE reports 78C 2008
46. Costs and benefits of measures to prevent needlestick injuries in a university hospital. Roudot-Thoraval F, Montagne O, Schaeffer A, Dubreuil-Lemaire ML, Hachard D, Durand-Zaleski I, Infect Cont and Hosp Epidemiol 1999 20 614 617 10.1086/501681
47. UK Health and Safety Executive, European Commission measures for protecting healthcare workers from infections due to needlestick injuries. Paper No. HSE/08/60 Bootle 2008
48. Costs associated with sharps injuries in the Swedish health care setting and potential cost savings from needle-stick prevention devices with needle and syringe. Glenngård AH, Persson U, Scand J Infect Dis 2009 41 296 302 10.1080/00365540902780232 19229763
49. Heinrich J, United States General Accounting Office: Occupational safety: selected cost and benefit implications of needlestick prevention devices for hospitals Washington DC, USA: United States General Accounting Office 2000
50. Willingness to pay to avoid sharps-related injuries: a study in injured health care workers. Fisman DN, Mittleman MA, Sorock GS, Harris AD, Am J Infect Control 2002 30 283 287 10.1067/mic.2002.124586 12163862 (Pubitemid 34852413)
51. Análisis coste-efectividad de dispositivos sanitarios diseñados para prevenir exposiciones percutáneas. Armadans Gil L, Fernández Cano MI, Albero Andrés I, Anglés Mellado ML, Sánchez García JM, Campins Martí M, Vaqué Rafart J, Gac Sanit 2006 20 374 381 10.1157/13093206 17040646
52. Underreporting of accidental exposures to blood and other body fluids in healthcare settings: an alarming situation. Roy E, Robillard P, Adv Expo Prev 1995 1 11
53. Barnett GS, Maclaine GDH, Economic analysis of the prevention of medical sharps injuries with safety-engineered devices: A systematic review [Abstract] Dublin: In press: to be presented at the 16th Annual International Society of Pharmacoeconomics and Outcomes Research European Congress 2013 2 6